RWE and HTA – a snapshot of recent developments with Sreeram Ramagopalan: May–July 2023

Written by Sreeram Ramagopalan (Lane Clark & Peacock)
Artificial intelligence and machine learning Comparative effectiveness research Guest columns Health technology assessment Industry Updates Interviews Rare diseases and orphan drugs Real-world evidence

Read highlights from the latest instalment of Sreeram Ramagopalan’s (Lane Clark & Peacock, UK) industry news round-up, which discusses some of the latest developments regarding real-world evidence (RWE) in the context of health technology assessment (HTA) and is published bi-monthly in our partner journal, the Journal of Comparative Effectiveness Research. Read the full update for May–July 2023 in the Journal of Comparative Effectiveness Research here >>> What happened over these months that you were expecting? I was expecting the guidance from CADTH for those undertaking and submitting RWE studies for regulatory and HTA decision making in Canada. Similar to the...

To view this content, please register now for access

It's completely free